thymoquinone has been researched along with Cancer of Ovary in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, W; Dong, J; Li, B; Li, R; Liu, X; Pan, Y | 1 |
| Barham, W; Khabele, D; Saskowski, J; Wilson, AJ; Yull, F | 2 |
| Abdelwahab, SI; Ahmadipour, F; Kamalidehghan, B; Khan, A; Mohan, S; Salim, LZ; Sheikh, BY; Taha, MM | 1 |
| Beale, P; Chan, C; Huq, F; Nessa, MU; Yu, JQ | 1 |
| Benghuzzi, H; Vance, S; Wilson-Simpson, F | 1 |
6 other study(ies) available for thymoquinone and Cancer of Ovary
| Article | Year |
|---|---|
The Effect of Thymoquinone on Apoptosis of SK-OV-3 Ovarian Cancer Cell by Regulation of Bcl-2 and Bax.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Cell Line, Tumor; Cisplatin; Drug Synergism; Female; Humans; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2 | 2017 |
Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer.
Topics: Animals; Apoptosis; Benzoquinones; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; NF-kappa B; Ovarian Neoplasms; Tumor Necrosis Factor-alpha | 2015 |
Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer.
Topics: Animals; Antinematodal Agents; Apoptosis; Benzoquinones; Cell Line, Tumor; Clodronic Acid; Disease Models, Animal; Female; Macrophages; Mice; Mice, Inbred C57BL; NF-kappa B; Ovarian Neoplasms | 2015 |
Thymoquinone induces apoptosis and increase ROS in ovarian cancer cell line.
Topics: Apoptosis; Benzoquinones; Blotting, Western; Cell Line, Tumor; Cell Survival; Female; HSP70 Heat-Shock Proteins; Humans; Membrane Potential, Mitochondrial; Nigella sativa; Ovarian Neoplasms; Reactive Oxygen Species | 2016 |
Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Benzoquinones; Cell Survival; Cisplatin; Drug Synergism; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Quercetin; Tumor Cells, Cultured | 2011 |
Physiological responses of ES-2 ovarian cell line following administration of epigallocatechin-3-gallate (EGCG), thymoquinone (TQ), and selenium (SE).
Topics: Antineoplastic Agents; Antioxidants; Benzoquinones; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Neoplasm Proteins; Ovarian Neoplasms; Selenium | 2007 |